- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.07 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 25 residues within 4Å:- Chain A: R.155, N.249, T.273, Q.300, G.301, A.302, G.303, E.304, A.305, V.334, D.335, S.336, K.337, K.351, V.379, A.380, A.381, I.382, L.406, S.407, N.408, G.433, G.452, N.454
- Ligands: 86I.3
22 PLIP interactions:22 interactions with chain A- Hydrophobic interactions: A:T.273
- Hydrogen bonds: A:N.249, A:Q.300, A:G.301, A:A.302, A:A.302, A:E.304, A:A.305, A:D.335, A:S.336, A:S.336, A:N.408, A:N.408, A:G.452
- Water bridges: A:E.304, A:K.337, A:K.351, A:K.351, A:N.454
- Salt bridges: A:R.155, A:K.337, A:K.351
NDP.5: 24 residues within 4Å:- Chain B: R.155, N.249, T.273, Q.300, G.301, A.302, G.303, E.304, A.305, V.334, D.335, S.336, K.351, V.379, A.380, A.381, I.382, L.406, S.407, N.408, G.433, G.452, N.454
- Ligands: 86I.6
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:T.273
- Hydrogen bonds: B:N.249, B:Q.300, B:G.301, B:A.302, B:A.302, B:E.304, B:E.304, B:A.305, B:D.335, B:S.336, B:S.336, B:N.408, B:N.408, B:N.408, B:G.452
- Water bridges: B:Q.300, B:K.351, B:K.351
- Salt bridges: B:R.155, B:K.351
NDP.8: 24 residues within 4Å:- Chain C: R.155, N.249, T.273, Q.300, G.301, A.302, G.303, E.304, A.305, V.334, D.335, S.336, K.337, K.351, V.379, A.380, A.381, I.382, L.406, S.407, N.408, G.433, G.452, N.454
17 PLIP interactions:17 interactions with chain C- Hydrophobic interactions: C:T.273
- Hydrogen bonds: C:N.249, C:Q.300, C:A.302, C:A.302, C:E.304, C:A.305, C:D.335, C:S.336, C:N.408, C:N.408, C:N.408, C:G.452
- Water bridges: C:N.454
- Salt bridges: C:R.155, C:K.337, C:K.351
NDP.11: 23 residues within 4Å:- Chain D: R.155, N.249, T.273, Q.300, G.301, A.302, G.303, E.304, A.305, V.334, D.335, S.336, K.351, V.379, A.380, A.381, I.382, L.406, S.407, N.408, G.433, G.452, N.454
19 PLIP interactions:19 interactions with chain D- Hydrophobic interactions: D:T.273
- Hydrogen bonds: D:N.249, D:Q.300, D:A.302, D:A.302, D:E.304, D:E.304, D:A.305, D:D.335, D:S.336, D:N.408, D:N.408, D:N.408, D:G.452
- Water bridges: D:R.155, D:R.155, D:G.303
- Salt bridges: D:R.155, D:K.351
- 4 x 86I: 6-[(7-methyl-2-propyl-imidazo[4,5-b]pyridin-4-yl)methyl]-2-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-1,3-benzothiazole(Non-covalent)
86I.3: 13 residues within 4Å:- Chain A: N.249, F.253, R.260, I.270, Q.271, G.303, E.304, L.307, G.308, H.311, E.350, D.475
- Ligands: NDP.2
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:N.249, A:F.253, A:I.270, A:I.270, A:L.307, A:D.475
- Hydrogen bonds: A:R.260
- Water bridges: A:T.348, A:T.348
- pi-Stacking: A:F.253, A:H.311, A:H.311
86I.6: 10 residues within 4Å:- Chain B: N.249, F.253, E.304, L.307, G.308, H.311, E.350, K.353, D.475
- Ligands: NDP.5
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:N.249, B:L.307, B:E.350
- pi-Stacking: B:F.253, B:F.253, B:H.311, B:H.311
86I.9: 11 residues within 4Å:- Chain C: N.249, F.253, R.260, Q.271, A.274, E.304, L.307, G.308, H.311, E.350, D.475
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:N.249, C:F.253, C:F.253, C:Q.271, C:A.274, C:L.307, C:E.350
- Hydrogen bonds: C:R.260
- pi-Stacking: C:F.253, C:H.311, C:H.311
86I.12: 15 residues within 4Å:- Chain D: N.249, V.250, F.253, R.260, I.270, Q.271, A.274, G.303, E.304, L.307, G.308, H.311, L.312, E.350, D.475
14 PLIP interactions:14 interactions with chain D- Hydrophobic interactions: D:N.249, D:V.250, D:F.253, D:I.270, D:Q.271, D:A.274, D:L.307, D:L.312, D:E.350
- Hydrogen bonds: D:R.260
- pi-Stacking: D:F.253, D:F.253, D:H.311, D:H.311
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yoshida, T. et al., Discovery and Characterization of a Novel Allosteric Small-Molecule Inhibitor of NADP + -Dependent Malic Enzyme 1. Biochemistry (2022)
- Release Date
- 2022-07-20
- Peptides
- NADP-dependent malic enzyme: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.07 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x 86I: 6-[(7-methyl-2-propyl-imidazo[4,5-b]pyridin-4-yl)methyl]-2-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-1,3-benzothiazole(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yoshida, T. et al., Discovery and Characterization of a Novel Allosteric Small-Molecule Inhibitor of NADP + -Dependent Malic Enzyme 1. Biochemistry (2022)
- Release Date
- 2022-07-20
- Peptides
- NADP-dependent malic enzyme: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D